Cramer Tries His Best to Top-Tick Amazon (AMZN), Sets Street High $210 Price Target Dec 2, 2009 03:16PM

Cramer just looooves to be the most outlandish (defined by dictionary.com as "remote from civilized areas") pundit/analyst on the Street, doesn't he?

Remember when Google (Nasdaq: GOOG) was trading over $700 in late 2007 and Cramer was adamant that the stock was headed well over $1,000? Or how 'bout a few months ago when Cramer just had to set the Street high price target on Apple (Nasdaq: AAPL) at $264? Following an article on RealMoney this morning, Cramer's next "victim" happens to be another tech-giant (and, in fact, a member of his cleverly-named "Four Horseman of Tech"), Amazon.com (Nasdaq: AMZN).

In his note to premium RealMoney subscribers earlier, Cramer said that the price action in Amazon this morning was "just so classic bull market behavior that you must sit up and take notice of this." This is probably a good time to point out that shares of Amazon.com have surged 177% year-to-date. Cramer believes that investors should be willing to pay-up for Amazon shares moving forward as the online retailer is demonstrating "accelerating growth, probably higher than the projected 25% growth". As Cramer follower's will know, he generally likes stocks that trade at (on a P/E basis) twice there growth rate. So, applying Cramer's 30-plus percent growth rate on Amazon earnings, he sees the stock trading at a 60 multiple soon. Now, going a little further with the math, times that by his $3.50 EPS estimate for next year, and Cramer now has a $210 price target -- of course the new Street high.

With shares of Amazon trading around $142.20 today, the stock would need to climb another almost 50% before hitting Cramer's new target.

Now hear me out: despite all the times I like to pick on Cramer, I am in fact a fan. I feel he serves as a great entertainment tool in a world full of often monotonous financial statements and complicated equations. But heed this warning... as far as his up, up and away price target calls go, they have yet to play out and sometimes even mark a near-term top in the stock.


Despite Novartis Denial, UBS Makes A Strong Case That They Should Buy Alcon (ACL) Dec 2, 2009 03:06PM

An analyst at UBS caused a flurry of speculation around Alcon Inc. (NYSE: ACL) today, sending the stock up over 5 percent after making its case that Novartis (NYSE: NVS) should take out the remaining shares of the company that it doesn't own.

UBS analyst Fabian Wenner said their analysis shows that Novartis will not be able to cover the deal’s cost of capital before 2021 unless it takes out the Alcon minorities on top of buying the 52% stake from Nestle in 2010. Wenner said the reason is "most measures to realize synergies have to be carried out at arms’ length which in our view limits the savings to c40% of the total potential."

The analyst suggested that assuming a deal gets done at a price of $181 per share for the minorities, Novartis would cover its cost of capital by 2016.

Responding to the speculation, Novartis told Bloomberg News that is has no plans to buy the minority shares. Well this is not slowing down the shares as UBS said, "the opportunity costs of delaying a full takeout are too high in our view" and suggests NVS can afford to pay $235.80 per minority share due to the $686 million in synergies. That's a nearly 50% premium from the current market price.

Well even if Novartis said it has no plans to takeout Alcon, UBS is making such an compelling reason for the deal that the company may want to take a look at this options. Speculators clearly see an opportunity as the stock has not slowed down on the denial news.


Get Market Moving News Alerts - 2 Week Free Trial http://www.streetinsider.com/premium_content.php


JPMorgan (JPM) Could See $3B Revenues Hit On Derivatives Rules Dec 2, 2009 01:08PM

Analysts at Sanford C. Bernstein said JPMorgan Chase (NYSE: JPM) may see revenues fall by up to $3 billion if derivatives trades move to exchanges under new rules, according to a report from Bloomberg.

Analyst John McDonald said this could mean a reduction in earnings per share of as much as 20 cents in a "worst case" situation. Derivatives accounted for about 8 percent of JPMorgan’s revenue from 2006 to 2008.


Goldman Issues 'Top Trades of 2010': Sees 2010, 2011 'Rather Strong Years', Gives Global, US, Euro, BRIC GDP Estimates Dec 2, 2009 12:44PM

In it's "Top Trades of 2010" report, just issued, Goldman Sachs has made some pretty interesting macro calls. Below are some highlights from the report:

  • sees 2010 and 2011 as "rather strong years"
  • sees global GDP growth of 4.4% in 2010 and 4.5% in 2011
  • expects lower-than-consensus inflation
  • says the risk to these calls is that the Fed will raise rates earlier than projected
  • sees U.S. GDP growth of 2.1% in 2010 and 2.4% in 2011
  • sees BRIC "real GDP growth" of 9.2% in 2010 and 8.6% in 2011
  • sees Euro-area GDP growth of 1.5% in 2010 and 1.9% in 2011
  • sees Japan GDP growth of 1.5% in 2010 and 1.6% in 2011
  • sees Russian "real GDP growth" of 4.5% in 2010
  • recommends going long the pound versus the New Zealand dollar
  • sees "steep acceleration" of U.K. GDP growth into 2011
  • says Ireland will outgrow its debt problem better than Spain


More Thoughts On Apple's (AAPL) Quick Sell-Off Yesterday Dec 2, 2009 12:14PM

Piper Jaffray analyst Gene Munster sent WSJ's MarketBeat blog some thoughts on why Apple (Nasdaq: AAPL) sold off so hard into the close yesterday.  It was widely reported that a possible T-Mobile deal was part of the reason for the selling.

Here is what he said:

"I heard four reasons why the stock got hit. 1.) T-Mobile getting the phone not Verizon 2.) soft retail sales 3.) greater competition from NOK, and 4.) Psystar trademark issues. In my opinion investors were stretching for reasons. None of them seem to have enough weight/truth to justify the drop in shares.

My take, there was a big seller for who knows what reason. People got worried they were missing something, and the stock tumbled. None of the mentioned reasons impact Apple's fundamentals."


Shares of Apple closed down 1.5% yesteday, and are up 0.7% today.


More Analyst Comments

View Older Stories

Dec 2, 2009 10:01AM Analyst Says Wal-Mart's Holiday Promotions 'Clearly a Negative' for GameStop; GME Down 7%
Dec 2, 2009 09:56AM Needham Lifts Price Target on Dyax (DYAX) to $8
Dec 2, 2009 09:38AM Citi Maintains a 'Buy' Rating on Bemis (BMS), Adds to 'Top Picks Live' List
Dec 2, 2009 09:05AM Standpoint Research Lifts Price Target on Cosan Ltd. (CZZ) to $12
Dec 2, 2009 08:34AM Airline Stocks Rising Again as Morgan Stanley Upgrades Sector to 'Attractive' (AMR, UAUA, ALK, ALGT)
Dec 2, 2009 08:30AM Hapoalim Securities Reiterates a 'Buy' on Protalix (PLX); Raises PT in Wake of Pfizer (PFE) Deal
Dec 2, 2009 08:24AM iPhone on Verizon? Not So Fast Says Analyst
Dec 2, 2009 07:28AM Auriga Reiterates a 'Buy' on Aeropostale (ARO); Long-Term Growth Initiatives Support Premium Valuation
Dec 2, 2009 07:11AM Goldman Sachs Raises Target on Express Scripts (ESRX) to $105
Dec 2, 2009 07:09AM FBR Research Maintains an 'Outperform' on Fairchild Semiconductor (FCS); Raises Estimates & PT
Dec 2, 2009 07:05AM FBR Research Reiterates an 'Outperform' on Zions Bancorp (ZION); Adjusts Estimates & PT
Dec 2, 2009 07:02AM Deutsche Bank Initiates Coverage on Dole Food (DOLE) with a Hold; Near-Term Headwinds May Pose a Challenge
Dec 2, 2009 06:50AM FBR Research Raises Price Target and 2010 Estimates on Amazon.com (AMZN)
Dec 1, 2009 04:27PM Apple (AAPL) Investors Show Nervousness On Speculation T-Mobile Could Be Next iPhone Carrier
Dec 1, 2009 03:45PM Positives Seen On BioCryst (BCRX) After Peramivir Granted Priority Review In Japan
Dec 1, 2009 02:58PM Baird Comments on Onyx Pharmaceuticals (ONXX) On China NDRL Update
Dec 1, 2009 02:44PM Goldman Sachs Lifts Price Target on WellCare (WCG) to $40
Dec 1, 2009 02:30PM Applied Materials (AMAT) Sees Upside and Option Investors Place Potentially Bullish Bets
Dec 1, 2009 02:29PM Canaccord Adams Reiterates a 'Buy' on Mosaic (MOS); Updates EPS Estimates After Business Realignment Announcement
Dec 1, 2009 02:12PM Morgan Stanley Lifts Price Target on InterOil (IOC) to $80, Says Continues to Exceed Expectations
Dec 1, 2009 02:02PM Ag Stocks Higher On Positive Analyst View That the "Worst is Over" (POT, MOS, AGU, MOO)
Dec 1, 2009 11:55AM Citi Maintains 'Buy' Rating on Pinnacle West (PNW); Removes from 'Top Picks Live' List
Dec 1, 2009 11:51AM Baird Reiterates a 'Neutral' Rating on Genzyme (GENZ); Long-Term Implications Still Evolving
Dec 1, 2009 10:47AM Credit Suisse Maintains an 'Outperform' on Packaging Corp of America (PKG), Adds to Focus List
Dec 1, 2009 09:34AM Wedbush Adds Bed Bath & Beyond (BBBY) to 'Best Ideas' List, Removes PetSmart (PETM)
Dec 1, 2009 09:25AM Bernstein Maintains a 'Market Perform' on United Technologies (UTX); PT to $73
Dec 1, 2009 08:55AM Kaufman Bros. Maintains a 'Buy' on CSG Systems (CSGS); DISH Overhang Removed
Dec 1, 2009 08:50AM Soleil Securities Maintains a 'Buy' on Las Vegas Sands (LVS); Comments on Sands China IPO
Dec 1, 2009 08:32AM RBC Maintains an 'Overweight' on EnCana (ECA), Slashes PT
Dec 1, 2009 08:06AM Wedbush Maintains a 'Neutral' on Endo Pharmaceuticals (ENDP); Adjusts Estimates & PT Ahead of Anticipated Aveed Approval
Dec 1, 2009 07:19AM Piper Jaffray Reiterates an 'Overweight' on Assured Guaranty (AGO); Fine-Tunes PT & Estimates
Dec 1, 2009 07:07AM Kaufman Bros. Reiterates a 'Buy' on Priceline.com (PCLN); Removes From Focus List
Dec 1, 2009 07:05AM Goldman Sachs Removed Abbott Labs (ABT) From Buy List, Eli Lilly (LLY) From Sell List
Dec 1, 2009 07:03AM Kaufman Bros. Reiterates a 'Buy' on Vistaprint NV (VPRT); Focus List Pick
Dec 1, 2009 06:50AM Piper Jaffray & Co. Reiterates an 'Overweight' on Guess? (GES); Raises Estimates & PT
Nov 30, 2009 04:11PM Analyst Sees Google (GOOG) Headed Higher
Nov 30, 2009 02:36PM RBC Lifts Price Target on Best Buy (BBY) to $49
Nov 30, 2009 12:11PM Broadpoint.AmTech Lowers Est and Price Target on Research In Motion (RIMM), But Sticks With Buy Rating
Nov 30, 2009 12:11PM Deere (DE) Shares Rising as Analysts Getting Bullish
Nov 30, 2009 11:44AM Soleil Calls Fertilizer Stocks 'Over-Valued', Recommends Taking Profits (POT, MOS, IPI)
Nov 30, 2009 11:17AM Broadpoint.AmTech Raises Price Target on Google (GOOG) to $650
Nov 30, 2009 11:13AM Kaufman Bros. Reiterates a 'Buy' on Vistaprint (VPRT)
Nov 30, 2009 10:57AM Downside in AIG Intensifies as Stock Giving Back Key Technical Levels (AIG)
Nov 30, 2009 10:44AM Canaccord Adams Reiterates a 'Speculative Buy' on Delcath Systems (DCTH); Raises Estimates & PT
Nov 30, 2009 10:07AM Goldman Says We're Entering Final Third of U.S. Bank Losses; Says Stress Test Was Enough (XLF, BAC, JPM, COF)
Nov 30, 2009 09:51AM Piper Jaffray Maintains an 'Overweight' on Apple (AAPL); Comments on Black Friday Sales
Nov 30, 2009 09:36AM American International Group (AIG): AIG Reserves Deficient - Sanford Bernstein
Nov 30, 2009 09:33AM Citigroup Lifts Price Target on Human Genome Sciences (HGSI) to $38
Nov 30, 2009 09:25AM RBC Capital Maintains an 'Outperform' on ArcSight (ARST); Raises PT
Nov 30, 2009 09:12AM Goldman Sachs Raises Price Target on Deere & Co (DE) to $57
View Older Stories